SCHEMBL4768684

SCHEMBL4768684

Cc1c[nH]c(C)c1CCC(=O)Nc1cc(-c2cccnc2)nc(-c2ccccn2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 8/20 0.43
ADORA1 P30542 7/20 0.43
ADORA3 P0DMS8 6/20 0.43
ADORA2B P29275 1/20 0.40
IDE P14735 1/20 0.39
KMT2A Q03164 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
ABL1 P00519 1/20 0.39
EGFR P00533 1/20 0.39
PDGFRB P09619 1/20 0.39
BCR P11274 1/20 0.39
PDGFRA P16234 1/20 0.39
PRKCA P17252 1/20 0.39
NOTUM Q6P988 1/20 0.38
CDC7 O00311 1/20 0.38
DAPK3 O43293 1/20 0.38
ROCK2 O75116 1/20 0.38
MAP4K4 O95819 1/20 0.38
PRKACA P17612 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4769061 0.82 ADORA2A (0.43) ADORA2AADORA1ADORA3ADORA2BIDE
SCHEMBL4766014 0.82 ADORA1 (0.47) ADORA2AADORA1ADORA3ADORA2BCYP3A4
SCHEMBL4771758 0.82 ADORA1 (0.43) ADORA2AADORA1ADORA3ADORA2BKMT2A
SCHEMBL4773065 0.81 ADORA1 (0.43) ADORA2AADORA1ADORA3ADORA2BCDC7
SCHEMBL4769102 0.81 KMT2A (0.55) ADORA2AADORA1ADORA3KMT2A
SCHEMBL4765953 0.78 LMNA (0.52) CYP2C9
SCHEMBL4770635 0.78 CYP1A2 (0.52) ADORA2AADORA1ADORA3CYP3A4EGFR
SCHEMBL4773415 0.77 ADORA2A (0.43) ADORA2AADORA1ADORA3ADORA2BIDE
SCHEMBL4768829 0.76 KDM4E (0.44) ADORA2AADORA1ADORA3ADORA2BKMT2A
SCHEMBL4775234 0.75 LMNA (0.49) CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1878733-A1 Pyrimidine derivatives as ALK-5 inhibitors Novartis AG (CH) 2008-01-16 EP disclosed